Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$266,893
+$1,720 QoQ
Shares Held
1,703
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,191
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 11%
None 12%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
This page
|
1,703 | $266,893 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,893 | 1,703 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $265,173 | 1,736 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $241,961 | 1,755 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $225,060 | 1,755 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $212,372 | 1,755 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $232,323 | 2,084 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $202,793 | 2,084 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $271,101 | 2,357 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $255,184 | 2,397 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $242,114 | 2,503 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $275,344 | 2,727 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $277,772 | 2,727 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $275,383 | 2,729 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $251,068 | 2,729 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $279,054 | 3,076 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $233,806 | 3,076 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $260,014 | 3,076 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $269,918 | 3,076 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $286,550 | 3,276 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $267,910 | 3,276 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $312,588 | 3,426 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $292,854 | 3,426 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $323,516 | 3,426 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $297,924 | 3,426 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $299,226 | 3,426 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $282,473 | 3,426 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||